Search hospitals
>
Iowa
>
Des Moines
Iowa Methodist Medical Center
Claim this profile
Des Moines, Iowa 50309
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Ovarian Cancer
347 reported clinical trials
4 medical researchers
Summary
Iowa Methodist Medical Center is a medical facility located in Des Moines, Iowa. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Ovarian Cancer and other specialties. Iowa Methodist Medical Center is involved with conducting 347 clinical trials across 477 conditions. There are 4 research doctors associated with this hospital, such as Joshua Lukenbill, Samantha L. Mallory, Robert J. Behrens, and Joshua Luckenbill.
Area of expertise
Breast Cancer
Iowa Methodist Medical Center has run 58 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Iowa Methodist Medical Center has run 51 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Joshua Lukenbill
Medical Oncology and Hematology Associates-Des Moines
3 years of reported clinical research
Samantha L. Mallory
Blank Children's Hospital
8 years of reported clinical research
Robert J. Behrens
Iowa Methodist Medical Center
5 years of reported clinical research
Joshua Luckenbill
Iowa Methodist Medical Center
4 years of reported clinical research
Clinical Trials running at Iowa Methodist Medical Center
Breast Cancer
Lung Cancer
Bladder Cancer
Breast cancer
Cancer
Prostate Cancer
Kidney Cancer
Small Cell Lung Cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting
2 awards
Phase 3
40 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting
2 awards
Phase 3
13 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
Recruiting
2 awards
Phase 3
23 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Iowa Methodist Medical Center?
Iowa Methodist Medical Center is a medical facility located in Des Moines, Iowa. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Ovarian Cancer and other specialties. Iowa Methodist Medical Center is involved with conducting 347 clinical trials across 477 conditions. There are 4 research doctors associated with this hospital, such as Joshua Lukenbill, Samantha L. Mallory, Robert J. Behrens, and Joshua Luckenbill.
Where is Iowa Methodist Medical Center located?
**Iowa Methodist Medical Center Visitor Information:** To reach the Iowa Methodist Medical Center in Des Moines, Iowa, exit I-235 at Keo Way south, turn right onto 12th Street, and follow the road up the hill to the campus. Visitor parking is available on both the north and south sides of the campus, as well as in the parking ramp on the west side.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Iowa Methodist Medical Center, part of UnityPoint Health: - Contact the Central Billing Office at (844) 849-1260 or email FA_CBO_Request@unitypoint.org for policy details and application assistance. - For insurance matters and payment options, bring your ID, insurance card, and driver's license to admitting/registration, or inquire about the Helping Hand Loan Program. - If you're facing difficulties paying your bill, reach out to the UnityPoint Health Billing Department at 1-844-849-1260 for support.
What insurance does Iowa Methodist Medical Center accept?
The Iowa Methodist Medical Center, located in Des Moines, Iowa, is part of UnityPoint Health. It has partnerships with various insurance companies, including HealthPartners, Medica, and Wellmark Blue Cross and Blue Shield of Iowa, suggesting these plans may be accepted. For a definitive list of accepted insurance plans, contact the hospital directly or visit their official website.
What awards or recognition has Iowa Methodist Medical Center received?
Iowa Methodist Medical Center has been endowed with $1 million for its Director position, highlighting its commitment to excellence. It is ranked #3 in Iowa and recognized in Central Iowa by U.S. News & World Report. The hospital also features a Virtual Research Data Center (VRDC), showcasing its dedication to advancing medical research.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.